• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

For Consumers

  • Print
  • Share
  • E-mail

FDA Office of Women's Health Update Archive

 

The words e-update with blue background

 

The Office of Women's Health e-Update highlights women's health initiatives, meetings, and regulatory safety information from the U.S. Food and Drug Administration (FDA). The e-Update is disseminated via email to the public. 

 

 

Current Issue - June 2014

 

 

Message from the Director

 
The Office of Women’s Health works to connect women with FDA resources on health issues ranging from pregnancy and heart health to menopause and cancer. In this eUpdate, we have included links to upcoming scientific workshops and advisory committee meetings on reproductive health as well as other research and educational resources. I hope you will share this update with your networks and encourage your followers to look to FDA's website for women's health information.

 

Marsha Henderson - Assistant Commissioner for Women’s Health 

 

***********************************

 

 

FDA and EPA issue draft updated advice for fish consumption

FDA and EPA have concluded pregnant and breastfeeding women, those who might become pregnant, and young children should eat more fish that is lower in mercury in order to gain important developmental and health benefits. The draft advice is to: Eat 8 to 12 ounces of a variety of fish each week from choices that are lower in mercury like salmon, shrimp, pollock, tuna (light canned), tilapia, catfish, and cod.

 

The draft updated advice cautions pregnant or breastfeeding women to avoid four types of fish that are associated with high mercury levels: tilefish from the Gulf of Mexico; shark; swordfish; and king mackerel. In addition, it recommends limiting consumption of white (albacore) tuna to 6 ounces a week.

 

Read more: Fish: What Pregnant Women and Parents Should Know 

 

 ***********************************

 

Updated Menopause Resources now Available

Updated materials on menopause and hormones are now available on the FDA website. The fact sheets answer common questions about menopause and hormones and the medication booklet provides basic information on FDA-approved hormone medicines for menopause. The menopause website also includes links to information on bio-identicals and compounded menopausal hormone therapy. These resources can be used to help women talk to their healthcare providers to find out if hormone therapy is right for them.

 

Get the facts on menopause and hormones at: www.fda.gov/menopause

  

*********************************** 

 

FDA Pregnancy Workshops at Teratology Conference

FDA is coordinating two sessions on pregnancy at the upcoming Teratology Society Meeting in Bellevue, Washington June 28 – July 2, 2014. The Office of Women’s Health and the Center for Biologics Evaluation and Research are co-chairing a symposium on Thrombosis during Pregnancy: Risks, Prevention and Treatment for Mother and Fetus on Wednesday, July 2nd and the Center for Drug Evaluation and Research, Pediatric Maternal Health Staff is co-chairing a session on Pregnancy Registries and Public Policy on Monday, June 30th.                                                                            

 

**********************************

Extras

 

New Website Helps the Public Learn How to Report Problems to FDA

FDA’s MedWatchLearn website teaches students, health professionals, and consumers how to complete the forms necessary to report problems to FDA. You can practice filling out forms for different types of problems with drugs or medical devices.

 

 

openFDA provides easy access to FDA public data

FDA launched openFDA, a new initiative designed to make it easier for web developers, researchers, and the public to access large, important public health datasets collected by the agency. openFDA will begin with an initial pilot program involving the millions of reports of drug adverse events and medication errors that have been submitted to the FDA from 2004 to 2013. The pilot will later be expanded to include the FDA’s databases on product recalls and product labeling.

 

Learn more at: open.FDA.gov

  

**********************************

 

FDA Meetings

 

 
 
********************************
 

OWH Conference Exhibits

 
  • YWCA - June 13, Washington, DC

  • American Diabetes Association - June 13-17, San Francisco, CA

  • Teratology Society – June 28 – July 2, Bellevue, WA  

  


Past OWH eUpdate Issues 

 

 

 

Contact FDA

301-796-9440
Fax:301-847-8604
Food and Drug Administration Office of Women's Health

10903 New Hampshire Avenue

WO32-2333

Silver Spring, MD 20993